Welcome to CSNpharm! For Research Use Only!
Home Compound Arrays Promotion +1-708-781-1677 sales@csnpharm.com    

PARP

PARP

Cat. No. Product Name CAS No. Information
CSN13901 Rucaparib Phosphate 459868-92-9 Rucaparib phosphate is an inhibitor of PARP with Ki of 1.4 nM for PARP1, also showing binding affinity to eight other PARP domains.
CSN13914 Rucaparib   283173-50-2 Rucaparib is an inhibitor of PARP with Ki of 1.4 nM for PARP1, also showing binding affinity to eight other PARP domains.
CSN17163 PJ34 344458-19-1 PJ34 is a potent specific inhibitor of PARPl2 with IC50 of 110 nM and 86 nM respectively
CSN13594 PJ34 HCl 344458-15-7 PJ34 HCl is a potent specific inhibitor of PARP-l2 with IC50 of 110 nM and 86 nM
CSN11806 Picolinamide   1452-77-3 Picolinamide is found to be a strong inhibitor of poly ADP-ribose synthetase of nuclei from rat pancreatic islet cells
CSN27556 Nudifloramide 701-44-0 Nudifloramide (2PY) is one of the end products of nicotinamide-adenine dinucleotide (NAD) degradation. Nudifloramide significantly inhibits poly(ADP-ribose) polymerase (PARP-1) activity in vitro.
CSN10181 NU1025 90417-38-2 NU1025 is a potent PARP inhibitor with IC50 of 400 nM
CSN16905 MN-64   92831-11-3 MN-64 is an inhibitor of tankyrases showed 6 nM potency against tankyrase 1 isoenzyme selectivity and Wnt signaling inhibition
CSN13146 MK-4827 1038915-60-4 MK-4827 is an excellent PARP1 and PARP2 inhibitor with IC50 of 38 and 21 nM respectively
CSN17047 INO-1001   3544-24-9 INO-1001 is a potent inhibitor of PARP with IC50 of 50 nM in CHO cells and a mediator of oxidant-induced myocyte dysfunction during reperfusion.
CSN24184 GeA-69 2143475-98-1 GeA-69 is a selective PARP14 inhibitor with Kd value of 2.1 µM, targeting on macrodomain 2.
CSN25274 BYK204165 1104546-89-5 BYK204165 is a potent and selective poly(ADP-ribose) polymerase (PARP)-1 inhibitor (pIC50 values are 5.38 and 7.35 for PARP-2 and PARP-1 respectively).
CSN12304 BSI-201   160003-66-7 BSI-201 is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC).
CSN12304 BSI-201   160003-66-7 BSI-201 is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC).
CSN12830 BGP-15   66611-37-8 BGP-15 is a nicotinic amidoxime derivative with PARP inhibitory activity It has been demonstrated that BGP-15 protects against ischemia-reperfusion injury
CSN22652 4-HQN   491-36-1 4-HQN is a PARP inhibitor with IC50 of 95 M
CSN23547 3-Methoxybenzamide 5813-86-5 3-Methoxybenzamide is a competitive poly(ADP-ribose) synthetase inhibitor with Ki value < 2 μM and also inhibits ADP-ribosyltransferase (ADPRT).
CSN27722 AZ9482   1825345-33-2
<< PREV 1 2 NEXT >>